BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 2, 2014
View Archived Issues
AbbVie disclose novel glucocorticoid receptor modulators
Read More
Prana Biotechnology reports preliminary data from phase II IMAGINE trial
Read More
First patient enrolled in phase III AN-2728 trial
Read More
Novel ultra-fast vaccine formulation shows safety and efficacy in phase IIb trial
Read More
Clinigen acquires Savene from SpePharm
Read More
Heron Therapeutics initiates label-expansion study of Sustol
Read More
Sorrento Therapeutics begins dosing in pivotal bioequivalence study of Cynviloq
Read More
Galectin Therapeutics reports biomarker results from first cohort in phase I trial in NASH
Read More
Anavex obtains exclusive rights to AF-710B to strengthen Alzheimer's pipeline
Read More
NIH funding to progress isradipine into phase III for Parkinson's disease
Read More
Jazz Pharmaceuticals and Gentium announce European launch of Defitelio
Read More
Clinical safety of abuse-deterrent analgesic formulations
Read More
Brazilian group prepares new agents for cancer
Read More
Halozyme Therapeutics' CONSISTENT 1 study of Hylenex meets primary endpoint
Read More
New MCHR-1 antagonists presented by Bristol-Myers Squibb
Read More
Boehringer Ingelheim patents novel sGC activators
Read More
FDA grants orphan drug status to Graspa for AML
Read More
Janssen submits NDA to the FDA for darunavir/cobicistat fixed-dose combination tablet
Read More
LCZ-696 trial in chronic heart failure closes early based on interim results
Read More
MicroRNAs may be biomarkers of drug-induced pancreatic injury
Read More
Lenvatinib receives orphan drug status from the FDA for two indications
Read More
OPKO Health launches 4Kscore test for prostate cancer
Read More
Guselkumab is an effective, well-tolerated therapy for psoriasis according to phase II results
Read More
Array CGH-SNP analysis may identify undetected cases of myelodysplastic syndromes
Read More
GSK ends MAGRIT study of MAGE-A3 cancer immunotherapeutic
Read More
FDA advisory committee recommends approval of Afrezza
Read More
FDA approves Oralair
Read More